Could a simple cream soothe eczema itch? small study hints at yes
NCT ID NCT07166497
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a cosmetic cream in 21 women with mild to moderate atopic dermatitis (eczema). Participants applied the cream daily for up to 31 days. Researchers measured skin severity, itching, sleep quality, and skin hydration. The goal was to see if the cream could help ease symptoms without medication.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cosmetic cream (RV4660C CY0203)
- What this could lead to
- If it works, this could point toward a gentle, non-medicated cream to help ease symptoms like itching and dryness for people with mild to moderate atopic dermatitis.
- What could go wrong
- This was a very small, early exploratory study with only 21 women and no comparison group. Results may not apply to men, children, or people with severe eczema, and the cream may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
21 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Dec 2023
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study is disseminated to the database of potential subjects by email and, if needed, by telephone, describing study title,name(s), address(es) and contacts of the study site(s), name of the Principal Investigator, the parameter(s) in study, study inclusion and exclusion criteria, study objective(s), groups of treatment, namely, if experimental or comparative products are tested, potential risks of adverse events and study duration. The subjects that manifested interest in participating in the study might be contacted by telephone. Screening questions are asked in order to screen the main inclusion and exclusion criteria Subjects' answers to the telephonic recruitment are evaluated by the Principal Investigator who decides if the subject is to be selected for the recruitment visit.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Main inclusion criteria : * Woman 18 years or older * Non-menopausal woman * Subject with phototype I, II, III, IV as classified by Fitzpatrick * Subject with AD according to "The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis" * Mild to moderate AD with SCORAD (SCORing Atopic Dermatitis) between 20 and 40 inclusive * Subject who had at least 1 inflammatory AD flare-up in target areas in the year prior to inclusion visit * Subject with at least one measuring target area on each upper or lower limb and defined as a typical AD flare-up area in the opinion of the subject * Subject with at least one target area on each upper or lower limb with the following SCORAD target signs (between 3 and 18): 1. Erythema ≥ 1 2. Xerosis \> 1 * Subject with pruritus intensity ≥ 3 on SCORAD analog visual scale (VAS) Main non-inclusion criteria: * Subject with superinfected AD * Subject with a known history of allergy or intolerance to the components of the study product * Subject with a dermatological condition other than AD, or characteristics (for example, tattoo) on the study areas, likely to interfere with the study evaluations according to the investigator's opinion * Subject with another dermatological condition, acute or chronic pathology, or history of pathology, likely to interfere with study evaluations, or considered dangerous to the subject or incompatible with study requirements, in the opinion of the investigator * Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational product according to the investigator's assessment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mild to moderate atopic dermatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Skin Research Center
Toulouse, France, 31000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.